Ligne de temps
Capucine Grandjean
Chercheur(euse) Permanent(e)
15 août 2025
publication
Reprogramming RIPK3-induced cell death in malignant B cells promotes immune-mediated tumor control.
Lire plus24 févr. 2025
01 avr. 2024
publication
Anti-PD-1 therapy triggers Tfh cell-dependent IL-4 release to boost CD8 T cell responses in tumor-draining lymph nodes.
Lire plus25 mars 2024
news
New publication – Anti-PD-1 therapy triggers Tfh cell–dependent IL-4 release to boost CD8 T cell responses in tumor-draining lymph nodes
Lire plus01 juil. 2023
publication
Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4+ CAR T-cell antitumor activity.
Lire plus05 juin 2023
news
New publication – Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4+ CAR T-cell antitumor activity
Lire plus02 avr. 2021
26 mars 2021
publication
A cross-talk between CAR T cell subsets and the tumor microenvironment is essential for sustained cytotoxic activity.
Lire plus19 févr. 2021
01 févr. 2021
publication
Imaging the mechanisms of anti-CD20 therapy in vivo uncovers spatiotemporal bottlenecks in antibody-dependent phagocytosis.
Lire plus23 oct. 2019
publication
Tumor Immunosurveillance and Immunotherapies: A Fresh Look from Intravital Imaging.
Lire plus01 avr. 2019
publication
Single-cell imaging of CAR T cell activity in vivo reveals extensive functional and anatomical heterogeneity.
Lire plus06 sept. 2017
publication
Increased TCR signal strength in DN thymocytes promotes development of gut TCRαβ(+)CD8αα(+) intraepithelial lymphocytes.
Lire plus04 oct. 2016
publication
Intravital imaging reveals improved Kupffer cell-mediated phagocytosis as a mode of action of glycoengineered anti-CD20 antibodies.
Lire plus15 juin 2015
11 mai 2015